Cases 1 - 10 of 155
ViiV Healthcare Company et al v. Hetero USA, Inc. et al
as 1:2024cv00657
Plaintiff:
ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited and Shionogi & Co., Ltd.
Defendant:
Hetero USA, Inc., Hetero Labs Limited Unit-V and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
ViiV Healthcare Company et al v. Hetero USA, Inc. et al
as 1:2024cv00547
Plaintiff:
ViiV Healthcare Company, Shionogi & Co., Ltd. and ViiV Healthcare UK (No. 3) Limited
Defendant:
Hetero USA, Inc., Hetero Labs Limited Unit-III and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
UCB, Inc. et al v. Prinston Pharmaceutical Inc. et al
as 1:2024cv00167
Plaintiff:
UCB, Inc. and UCB Biopharma SRL
Defendant:
Prinston Pharmaceutical Inc. and Zhejiang Huahai Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Prinston Pharmaceutical Inc. et al
as 1:2024cv00152
Plaintiff:
AbbVie Inc.
Defendant:
Prinston Pharmaceutical Inc., Zhejiang Huahai Pharmaceutical Co., Ltd. and Solco Healthcare US, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities Ltd. et al
as 1:2023cv01193
Plaintiff:
Taiho Pharmaceutical Co., Ltd. and Taiho Oncology, Inc.
Counter Claimant:
Eugia Pharma Specialities Ltd.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Meitheal Pharmaceuticals, Inc. et al
as 1:2023cv01195
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Meitheal Pharmaceuticals, Inc. and Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Intellectual Property Gmbh, et al. v. Auson Pharmaceuticals Inc., et al.
as 1:2023cv01103
Counter Defendant:
Bayer Intellectual Property GMBH
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals Inc.
Defendant:
Auson Pharmaceuticals, Inc. and Auson Pharmaceuticals Co., Ltd.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Astellas Pharma Inc. et al v. Lupin Ltd. et al
as 1:2023cv00819
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Defendant:
Lupin Ltd., Lupin Pharmaceuticals, Inc., Sandoz Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals US, Inc. et al v. MSN Laboratories Private Ltd. et al
as 1:2023cv00731
Plaintiff:
Actelion Pharmaceuticals US, Inc., Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd.
Defendant:
MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. v. Apotex Inc. et al
as 1:2023cv00710
Plaintiff:
Otsuka Pharmaceutical Co., Ltd.
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
